HIV infection in older patients in the HAART era-Reference-Cited by-同舟云学术

HIV infection in older patients in the HAART era

Published:2005-11-11 Issue:1 Volume:57 Page:4-7
ISSN:1460-2091
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Grabar Sophie,Weiss Laurence,Costagliola Dominique

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/57/1/4/2710937/dki411.pdf

Reference34 articles.

1. Grabar S, Kousignian I, Sobel A et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS2004; 18: 2029–38.

2. Mack K, Ory M. AIDS and older Americans at the end of the twentieth century. J Acquir Immune Defic Syndr2003; 33: S68–75.

3. Centers for Disease Control and Prevention. AIDS cases in adolescents and adults,by age—United States, 1994–2000. HIV/AIDS Surveill Suppl Rep2003; 9: 1–24.

4. Delfraissy J. Prise en charge thérapeutique des personnes infectées par le VIH. Recommandations du groupe d'experts. Rapport 2004, p. 284. Paris: Flammarion Médecine-Sciences, 2004.

5. Castilla J, Sobrino P, De La Fuente L et al. Late diagnosis of HIV infection in the era of highly active antiretroviral therapy: consequences for AIDS incidence. AIDS2002; 16: 1945–51.

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment‐naïve people living with HIV aged 50 years or older in Beijing, China, 2010–2020: joinpoint regression model analysis of surveillance data;Journal of the International AIDS Society;2023-12

2. Metabolic Syndrome Among Human Immunodeficiency Virus Patients on Antiretroviral Therapy Attending Clinic at a District Hospital in Ghana;SN Comprehensive Clinical Medicine;2023-06-20

3. Decrease in CD4 T-Cell Count and Risk of Severe Morbid Conditions in People With Human Immunodeficiency Virus Infection With Controlled Viral Load After Initiating Combination Antiretroviral Therapy Between 2006 and 2018;Clinical Infectious Diseases;2022-12-17

4. Antiretroviral drug–drug interactions: A comparison of online drug interaction databases;Journal of Clinical Pharmacy and Therapeutics;2022-09-04

5. Fluorine Modifications Contribute to Potent Antiviral Activity against Highly Drug-Resistant HIV-1 and Favorable Blood-Brain Barrier Penetration Property of Novel Central Nervous System-Targeting HIV-1 Protease Inhibitors In Vitro;Antimicrobial Agents and Chemotherapy;2022-02-15